1 / 26

PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007

PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007. http://www.pdig.org.uk/. Improving procurement in the NHS Chris Theaker Director, Pharmaceuticals 8 November 2007. Improving procurement in the NHS . collaborative procurement  avoiding litigation  third party suppliers.

tailynn
Download Presentation

PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PROCUREMENT & DISTRIBUTION INTEREST GROUPAutumn Symposium 2007 http://www.pdig.org.uk/

  2. Improving procurement in the NHS Chris Theaker Director, Pharmaceuticals 8 November 2007

  3. Improving procurement in the NHS • collaborative procurement  • avoiding litigation  • third party suppliers

  4. Collaborative procurement • collaborative procurement developments • working with pharmacists • Joint Category Working Group • information systems

  5. Collaborative procurement • NHS PASA and Commercial Directorate • NPSG role • collaborative procurement hubs

  6. Building capacity and capability in the NHS - CPHs • all SHAs to have a hub available for every NHS Trust by March 2008 • 8 passed business case stage and are either fully mobilised or in the process of mobilisation • South West business case finalised and under review • London (LPP) developing its strategic sourcing model

  7. CPH roll out status by SHA – October 2007 • North East • North West • Yorkshire & the Humber • East Midlands • West Midlands • East of England • London • South East Coast • South Central • South West • Mobilised pre-April 2007: • North West CPH • West Midlands (HPC) • East Midlands (re:source) • South Central (PRO-CURE) Mobilised from April 2007: • East of England • South East Coast • Yorkshire and the Humber • North East (PRO-NE) CPH opportunity assessment: • South West – CPH business case proposal Sept 2007 Strategic sourcing opportunity assessment phase 2: • London – London Procurement Programme (LPP) 1 1 2 3 3 3 2 2 4 5 6 5 4 5 6 6 9 10 8 9 10 8 10 7

  8. Collaborative procurement hubs • deliver £270 million savings by 2007 • improved support for clinicians and clinical networks by increasing their involvement in purchasing • reduced clinical risk and enhanced patient safety strategies • stronger partnerships with suppliers through commitment to contracts and a focused route into the health economy • encouragement for innovation and provision of support for R&D in emerging treatments and technologies • building a robust, sustainable environment for procurement specialists through improved career structure and enhanced recruitment and retention • category focus – building capacity and capability to address complex categories and procurements e.g. mental health service, as well as traditional commodities

  9. National strategy • strategic framework to source pharmaceuticals 2005 • terms of reference • roles of NPSG, PMSG • links with hubs

  10. National strategy • role of regional groups • national sourcing (SCEP) • pharmaceutical products and services

  11. Terms of reference of JCWG • strategic procurement issues • inform procurement strategies • share workplans • commercial policy

  12. Pharmaceutical products and services list (1) • developed via discussion with pharmacists and procurement colleagues • supports strategic framework 2005 • defines category purchasing levels • sourcing role/pharmaceutical input

  13. Pharmaceutical products and services list (2) • national • CPH • trust • NHSSC

  14. Pharmaceutical products and services list (3) • clotting factors • homecare services • medical gases • IV fluids • branded medicines • wholesaler agreements • X-ray contrast media • bulk disinfectants

  15. Other aspects of collaboration • information exchange • terms and conditions • stakeholder communication • relations with industry • training and development • data

  16. Sustainable procurement • stakeholder workshop – October 2007 • sustainable procurement action plan • consultation / discussion

  17. Information systems • Pharmacy Business Technology Group • NHS Procurement eEnablement Group • UKPMS • Coding for success • GS1 Healthcare UK Group

  18. Information systems - PharmEx • activity reporting • procurement information • uptake • patient safety information • reporting / relationships with DH • quality control

  19. Collaborative procurement - summary • national framework • consistency • regional flexibility • local input • future developments

  20. Avoiding litigation • NHS PASA procedures • clarity and information • meeting trade organisations • good practice guidelines • supplier briefings

  21. Access to contracts (1) • current approach • market development • trade bodies • discussion at NPSG  • discussion with providers

  22. Access to contracts (2) • visibility of data • role of PharmEx • clarity of definition of NHS patients • procedures and processes

  23. Access to contracts – checklist • NHS patients • secondary care access • availability of data • supply arrangements

  24. Access to contracts – next steps • continuing dialogue • industry input • NPSG report • agreement of a policy document

  25. Summary • pharmacists’ key role • national / regional strategies • dialogue with suppliers • procurement collaboration • flexible approach

  26. Questions Chris Theaker Director, Pharmaceuticals chris.theaker@pasa.nhs.uk

More Related